BCL-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia

Cancer Research - United States
doi 10.1158/0008-5472.can-18-0236
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Integrin Alpha4 as a Therapeutic Target of Acute Lymphoblastic Leukemia

Journal of Blood Disorders & Transfusion
2014English

Novel Immunotherapies for Adult Patients With B-Lineage Acute Lymphoblastic Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

miRNAs in Acute Lymphoblastic Leukemia: Diagnosis, Prognosis and Target Therapeutic

2019English

High-Resolution Allelotype Analysis of Childhood B-Lineage Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1998English

P53-Mdm2 Pathway: Evidences for a New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia

Frontiers in Pharmacology
Pharmacology
2016English

Pre-T Cell Receptor Signaling Drives Leukemogenesis and Is a Therapeutic Target in T Cell Acute Lymphoblastic Leukemia

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Attenuated Measles Virus Controls Pediatric Acute B-Lineage Lymphoblastic Leukemia in NOD/SCID Mice

Haematologica
Hematology
2014English

EphA3 as a Target for Antibody Immunotherapy in Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2016English

Differential CD95 Expression and Function in T and B Lineage Acute Lymphoblastic Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy